This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Par Petroleum (PARR) Moves 6.8% Higher: Will This Strength Last?
by Zacks Equity Research
Par Petroleum (PARR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PARRPositive Net Change RGCOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
U.S. Steel (X) Moves 16.2% Higher: Will This Strength Last?
by Zacks Equity Research
U.S. Steel (X) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
TXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?
by Zacks Equity Research
Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RGENNegative Net Change ZLDPFNo Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Garrett Motion (GTX) Surges 9.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Garrett Motion (GTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GTXPositive Net Change DNZOYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Dream Finders Homes (DFH) Moves 5.1% Higher: Will This Strength Last?
by Zacks Equity Research
Dream Finders Homes (DFH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DFHNegative Net Change TMHCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beazer (BZH) Surges 7.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Beazer (BZH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BZHNegative Net Change PHMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Hovnanian (HOV): Can Its 10.6% Jump Turn into More Strength?
by Zacks Equity Research
Hovnanian (HOV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
HOVNegative Net Change BZHNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
D.R. Horton (DHI) Moves 4.6% Higher: Will This Strength Last?
by Zacks Equity Research
D.R. Horton (DHI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DHINegative Net Change PHMNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Gap (GAP): Can Its 7.2% Jump Turn into More Strength?
by Zacks Equity Research
Gap (GAP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
GAPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Journey Medical (DERM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DERMNo Net Change ASRTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Crocs (CROX): Can Its 4.9% Jump Turn into More Strength?
by Zacks Equity Research
Crocs (CROX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CROXPositive Net Change GILNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Savers Value (SVV) Soars 8.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Savers Value (SVV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
SVVNegative Net Change GILNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kohl's (KSS) Soars 8.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Kohl's (KSS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KSSNegative Net Change DDSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Novavax (NVAX) Soars 11.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
NVAXNegative Net Change TVTXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Centene (CNC): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
CNCPositive Net Change HUMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ELVNegative Net Change CDNAPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Tele2 (TLTZY): Can Its 7.8% Jump Turn into More Strength?
by Zacks Equity Research
Tele2 (TLTZY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TLTZYPositive Net Change TEONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SBA Communications (SBAC) Moves 5.3% Higher: Will This Strength Last?
by Zacks Equity Research
SBA Communications (SBAC) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO per share estimate revisions for the stock suggests that there could be more strength down the road.
SBACPositive Net Change ARENegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Core Scientific, Inc. (CORZ) Surges 5.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Core Scientific, Inc. (CORZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CORZNegative Net Change WTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Dianthus Therapeutics, Inc. (DNTH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DNTHPositive Net Change TECHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last?
by Zacks Equity Research
Arcutis Biotherapeutics (ARQT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ARQTPositive Net Change CDXSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ViaSat (VSAT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
VSATNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Avidity Biosciences (RNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RNAPositive Net Change MIRMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PDEXPositive Net Change WSTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Rocket Companies (RKT) Moves 10.0% Higher: Will This Strength Last?
by Zacks Equity Research
Rocket Companies (RKT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RKTNegative Net Change COOPNegative Net Change VELPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today